CYSLTR1 and neoplasm: Furthermore, in double-mutant Cysltr1-/-/ApcMin/+ mice, a significant reduction of the tumor burden was observed compared to control littermates, and this effect was accompanied with decreased systemic inflammation indicated by PGE2 levels [12].